Zobrazeno 1 - 10
of 19
pro vyhledávání: '"David C. Rice"'
Autor:
Mara B. Antonoff, Wayne L. Hofstetter, Garrett L. Walsh, Boris Sepesi, Jack A. Roth, Ravi Rajaram, Ara A. Vaporciyan, David C. Rice, Stephen G. Swisher, Kyle G. Mitchell, Erin M. Corsini, Nicolas Zhou, Reza J. Mehran
Publikováno v:
Journal of Gastrointestinal Surgery. 25:2185-2191
Most patients undergoing esophagectomy will experience intermittent reflux of gastric and biliary content into the remnant esophagus postoperatively. The incidence of new or recurrent intestinal metaplasia following chemoradiation and surgery has not
Autor:
Kyle G. Mitchell, Edwin R. Parra, Jiexin Zhang, David B. Nelson, Erin M. Corsini, Pamela Villalobos, Cesar A. Moran, Ferdinandos Skoulidis, Ignacio I. Wistuba, Junya Fujimoto, Jack A. Roth, Mara B. Antonoff, J. Jack Lee, Ara A. Vaporciyan, Wayne L. Hofstetter, Reza J. Mehran, Stephen G. Swisher, David C. Rice, Boris Sepesi, Garrett L. Walsh, Carmen Behrens, Neda Kalhor, Annikka Weissferdt, John V. Heymach, null AstraZeneca, null Bayer, null GlaxoSmithKline
Publikováno v:
Ann Thorac Surg
BACKGROUND: Mutations in the serine-threonine kinase LKB1/STK11 have been implicated in mediating resistance to checkpoint blockade among patients with advanced lung adenocarcinoma. We sought to examine the associations between clinicopathologic char
Autor:
David C. Rice
Publikováno v:
Atlas of Minimally Invasive and Robotic Esophagectomy ISBN: 9783030556686
Esophageal carcinoma is the eighth most common cancer worldwide and the sixth most common cause of cancer-related death. Although squamous cell carcinoma (ESCC) represents the most common histology, in the United States and many other Western countri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce45e20ee5381166e34de81ce9c626db
https://doi.org/10.1007/978-3-030-55669-3_4
https://doi.org/10.1007/978-3-030-55669-3_4
Autor:
Barbara Mino, J. Jack Lee, John V. Heymach, David C. Rice, Lixia Diao, Boris Sepesi, Luisa M. Solis, Debora A. Ledesma, Ruth Salazar, Humam Kadara, Ignacio I. Wistuba, Pamela Villalobos, Neda Kalhor, Cesar A. Moran, Annikka Weissferdt, Xiuning Le, Don L. Gibbons, Pedro Rocha, Dzifa Y. Douse, Carmen Behrens, Edwin Parra-Cuentas, Ara A. Vaporciyan, Hitoshi Dejima, Kyle G. Mitchell, Jianjun Zhang, Jiexin Zhang, Tina Cascone, Jose Luis Solorzano
Publikováno v:
Cancer Immunology, Immunotherapy. 70:1977-1978
The original version of this article unfortunately contained a mistake.
Autor:
Ara A. Vaporciyan, Garrett L. Walsh, Boris Sepesi, David C. Rice, Wayne L. Hofstetter, Reza J. Mehran, Stephen G. Swisher, Quynh Nhu Nguyen, Mara B. Antonoff, Arlene M. Correa
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 154:689-699
Objective For inoperable patients with pulmonary malignancy, stereotactic body radiotherapy is a reasonable therapeutic option. Despite good early tumor control, local failure occurs in up to 10% of patients by 3 years. Because management of local re
Autor:
Marta L. Davila, Raquel E. Davila, Xuemei Wang, Wayne L. Hofstetter, Mariela A. Blum Murphy, Jeffrey H. Lee, Fatemeh G. Amlashi, Manoop S. Bhutani, Dipen M. Maru, Jaffer A. Ajani, Brian Weston, David C. Rice, Kazuto Harada, Dilsa Mizrak Kaya, Quynh Nhu Nguyen, Maria Vassilakopoulou
Introduction: Barrett’s esophagus (BE) may be present in patients with esophageal adenocarcinoma (EAC) after bimodality therapy (BMT). There is no specific guidance for follow-up of these patients with regard to the presence of BE or dysplasia. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23a11802482f7cb949faf1af40ca2607
https://europepmc.org/articles/PMC6067962/
https://europepmc.org/articles/PMC6067962/
Autor:
Graciela M. Nogueras-Gonzalez, David C. Rice, Roopma Wadhwa, Nikolaos Charalampakis, Mariela A. Blum, Heath D. Skinner, Nastaran Neishaboori, Jaffer A. Ajani, Adarsh Hiremath, Jane E. Rogers, Brian Weston, Wayne L. Hofstetter, Jeffrey H. Lee, Jeana L. Garris, Stephen G. Swisher, Hironori Shiozaki, Ritsuko Komaki, Manoop S. Bhutani, Kazuki Sudo, Elena Elimova
Publikováno v:
Oncology. 89:65-69
Background: We have limited knowledge of the geographic distribution of resistant esophageal adenocarcinoma (EAC) in resected specimens, but its clinical importance can be enormous. Method: We selected patients with baseline stage III EAC who had had
Autor:
David B. Nelson, Wayne L. Hofstetter, Sonia L. Betancourt, Riham Katkhuda, Rajeev Dhupar, Boris Sepesi, Raquel E. Davila, Reza J. Mehran, David C. Rice, Alexei A. Goltsov, Mara B. Antonoff, Jaffer A. Ajani, Ara A. Vaporciyan, Marta L. Davila, Dipen M. Maru, Arlene M. Correa
Publikováno v:
The Journal of thoracic and cardiovascular surgery. 156(1)
Objectives Endoscopic mucosal resection (EMR) is a diagnostic and potentially therapeutic option for patients with submucosal esophageal adenocarcinoma. However, there are significant concerns regarding the risk of lymph node metastasis. Our purpose
Autor:
Bing Sun, David C. Rice, J. Welsh, Peter A Balter, John V. Heymach, Stephen M. Hahn, Eric D. Brooks, Boris Sepesi, Melenda Jeter, Daniel R. Gomez, Mary Frances McAleer, Joe Y. Chang, Michael S. O'Reilly, Ritsuko Komaki, Zhongxing Liao
Objectives Our goal was to evaluate stereotactic ablative radiotherapy (SABR) as a salvage option for isolated recurrence of NSCLC in the lung parenchyma after definitive treatment of stage I to III disease. Methods Patients who had histologically co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec7875db790b1e02ab9ceae21791e731
https://europepmc.org/articles/PMC5881570/
https://europepmc.org/articles/PMC5881570/
Autor:
Lucian R. Chirieac, Jaffer A. Ajani, Frederick L. Greene, Ara A. Vaporciyan, Wayne L. Hofstetter, Alexandria T. Phan, Kelly K. Hunt, Nipun B. Merchant, Garrett L. Walsh, Kelly M. McMasters, Jack A. Roth, Ritsuko Komaki, Zhongxing Liao, David C. Rice, Tsung T. Wu, Joseph Locicero, Edward M. Copeland, Stephen G. Swisher, Arlene M. Correa, Stephen B. Vogel, Gerard M. Doherty
Publikováno v:
Annals of Surgery. 241:810-820
Carcinoma of the esophagus and gastroesophageal junction (GEJ) is an aggressive disease with a poor prognosis.1–3 Because of poor outcomes with surgery alone, an increasing number of patients with locoregionally advanced esophageal cancer are treat